March 30 2020: Maimon releases working paper on deconstructing imaginary worlds and standards for real world evidence.
March 20 2020: Maimon issues working paper to deconstruct University of Washington report on NASH with fibrosis
March 16 2020: Maimon posts two working papers to demolish ICER's sickle cell final evidence report as failing standards of normal science
March 11 2020: Maimon deconstructs ICER model analysis plan for ulcerative colitis
March 1 2020: Maimon announces draft ICER Deconstruction working paper
February 28, 2020: Maimon has published the first two Maimon Working Papers (see section) on Cystic Fibrosis and Migraine
February 26, 2020: Maimon launches a pre-publication and review series of reports: Maimon Working Papers. These summarize the latest studies by Maimon Research on health technology assessment and often meaningless claims for cost-effectiveness, pricing and access by groups such as the Institute for Clinical and Economic Review (ICER)..
Langley P. More Unnecessary Imaginary Worlds – Part 3: Cystic Fibrosis and the Institute for Clinical and Economic Review’s Draft Evidence Report. Inov Pharm;11(1):No. 15
Langley PC. Nonsense on Stilts – Part 1: The ICER 2020-2023 Value Assessment Framework for Constructing Imaginary Worlds. InovPharm. 2020;11(1):No. 12 https://pubs.lib.umn.edu/index.php/innovations/article/view/2444
Langley PC. More Unnecessary Imaginary Worlds – Part 2: The ICER Evidence Report on Modeling Oral Semaglutide for Type 2 Diabetes. Inov Pharm. 2020;11(1):No 10
Langley PC. More Unnecessary Imaginary Worlds - Part 1: The Institute for Clinical and Economic Review’s Evidence Report on Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis. Inov Pharm . 2020;11(1):No 2